Israel Prepares For Clash With U.S., E.U. Over Drug Patent Policy

Law360, New York (September 13, 2004, 12:00 AM EDT) -- The Israeli government is preparing for an outright confrontation with the U.S. government and pharmaceutical industry with its plans to essentially confine patent rights for drugs to marketing exclusivity, according to reports.

The cabinet’s intention to approve a proposed change in protection for intellectual property rights of international pharmaceutical companies threatens “a crisis in U.S.-Israel trade relations,” financial daily Globes reported.

The proposal under consideration does not meet the demands of U.S. Trade Representative Robert Zoellick, who has threatened to put Israel back on the "priority...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.